Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
viviani bono
(6 results)?
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC).
Adv Ther. 2019 Oct;36(10):2600-2617. doi: 10.1007/s12325-019-01057-7. Epub 2019 Aug 20.
Adv Ther. 2019.
PMID: 31432460
Free PMC article.
Review.
Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register.
Lim LL, Lau ESH, Cheung JTK, Chan SP, Ji L, Lim S, Sirinvaravong S, Unnikrishnan AG, Luk AOY, Cortese V, Durocher A, Chan JCN.
Lim LL, et al.
Diabetes Obes Metab. 2023 Jan;25(1):208-221. doi: 10.1111/dom.14865. Epub 2022 Sep 26.
Diabetes Obes Metab. 2023.
PMID: 36082513
Free PMC article.
Item in Clipboard
Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (JADE) Register.
Lim LL, S H Lau E, Pheng Chan S, Ji L, Lim S, Sirinvaravong S, Unnikrishnan AG, O Y Luk A, Cortese V, Durocher A, C N Chan J.
Lim LL, et al.
Diabetes Res Clin Pract. 2023 Sep;203:110855. doi: 10.1016/j.diabres.2023.110855. Epub 2023 Jul 28.
Diabetes Res Clin Pract. 2023.
PMID: 37517776
Free article.
Item in Clipboard
Cite
Cite